Search for: [Abstract = "ificant. Concomitant diseases such as diabetes mellitus or diabetes mellitus did not influence the kidney function after the radioisotope treatment. The chromogranin A was assessed in 22 NET patients before and after the treatment with labelled somatostatin analogue. However no statistically significant difference in chromogranin A was found in all 22 patients, in 16 th of them mean values of chromogranin A was lower. The treatment with labelled somatostatin analogue did not result in the worsening of the liver function. In 13 patients increase in AlAT levels was observed during single measurements performed in different time after the treatment. In NHL subgroup the changes in CBC after the RIT were more pronounced than in NET subgroup, particularly in neutrophils, WBC count and PLT count. Mean PLT count was less than 100000\/mm3 in 4 week after the therapy, reached its nadir in the 6 week \(mean values of PLT \- 48000\/mm3\), and gradually increased after that time. However mean values of PLT count were significantly lower than the basal values, although they approached the lower normal limits.Fourth grade toxicity was observed in 15 patients \(50% of the subgroup\) and lasted in most patients for 2\-3 weeks and in 1 patient for 8 weeks. Third grade toxicity developed in 5 patients \(16,6%\) and in 2 of them lasted for 5 weeks and in 1 patient 11 weeks. The platelets concentrate transf"]

Number of results: 1